GlassScriptPhysician profile
Cara H Lieberman
NPI 1962465963
$3,531.42
in general payments reported to CMS, 2019-2025
19 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $246 · 2021: $545 · 2022: $647 · 2023: $288 · 2024: $464 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351 · Education: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.34 |
| Education | $438.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $908.75 | 2020-2025 | Veozah |
| Abbvie INC. | $815.94 | 2020-2024 | |
| Pfizer INC. | $339.58 | 2019-2025 | |
| Exeltis, USA INC. | $225.29 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $220.58 | 2021-2025 | |
| Amgen INC. | $200.99 | 2021-2025 | Evenity |
| Sumitomo Pharma America, INC. | $176.11 | 2025 | Gemtesa, Myfembree |
| Merck Sharp & Dohme LLC | $152.93 | 2019-2025 | Gardasil 9 |
| Harmony Biosciences LLC | $137.83 | 2020-2021 | |
| Coopersurgical, INC. | $69.54 | 2022-2024 | Paragard T 380a |
| Kowa Pharmaceuticals America, INC. | $55.72 | 2021 | |
| Daiichi Sankyo INC. | $53.76 | 2020 | |
| Millicent US INC | $43.50 | 2025 | Femlyv |
| Lilly USA, LLC | $35.42 | 2021 | |
| Avion Pharmaceuticals | $31.65 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $22.41 | 2019 | |
| Virtus Pharmaceuticals LLC | $15.11 | 2021 | |
| Vistapharm, INC. | $14.49 | 2021 | |
| Glaxosmithkline, LLC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Lieberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.